None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age: Adults aged 19 years or older (no upper age limit) Sex: Both male and female participants are eligible Diagnosis: Patients diagnosed with degenerative lumbar spine diseases (ICD-10 codes including M48.06, M48.07, M43.16, M47.26, M51.16, M54.16) Surgical procedure: Scheduled for single-level lumbar fusion surgery Anesthesia: Planned to undergo general anesthesia with total intravenous anesthesia (TIVA) Physical status: ASA physical status I–II Consent: Ability to provide written informed consent after receiving adequate explanation of the study
Exclusion criteria
Exclusion criteria: Patients receiving systemic immunosuppressive agents or systemic corticosteroids Patients with severe hepatic or renal dysfunction Patients with active infectious or inflammatory diseases Patients with a history of drug hypersensitivity reactions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum interleukin-6 (IL-6) concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| White blood cell count (WBC);Neutrophil-to-Lymphocyte Ratio, NLR;C-reactive protein;Postoperative pain score using the Visual Analog Scale (VAS);Intraoperative opioid consumption;Total opioid consumption during the first 24 hours postoperatively (0–24 h) | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital